Table 1.
Demographic characteristics of the sample.
| TRAINING | VALIDATION | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIGH FATIGUE (N = 18) | LOW FATIGUE (N = 9) | HIGH FATIGUE (N = 7) | LOW FATIGUE (N = 10) | |||||||||
| MEAN (SD) | RANGE | N (%) | MEAN (SD) | RANGE | N (%) | MEAN (SD) | RANGE | N (%) | MEAN (SD) | RANGE | N (%) | |
| Age in Years | 64.6 (5.7) | 53–73 | 65.2 (7.0) | 55–74 | 66.7 (5.3) | 58–73 | 6 6.5(7.0) | 53–74 | ||||
| Ethnicity n(%) | ||||||||||||
| Caucasian | 18 (100) | 7 (78) | 2 (29) | 5 (50) | ||||||||
| African-American | 2 (22) | 4 (57) | 4 (40) | |||||||||
| Other | 1 (14) | 1 (10) | ||||||||||
| Clinical T stage | ||||||||||||
| T1 (a–c) | 4 (22) | 2 (22) | 2 (29) | 2 (20) | ||||||||
| T2 (a–c) | 10 (56) | 7 (78) | 3 (43) | 7 (70) | ||||||||
| T3 (a–c) | 4 (22) | 2 (29) | 1 (10) | |||||||||
| BMI | 30.3 (4.5) | 22–37 | 30.4 (2.7) | 26–34 | 30.4 (6.3) | 24–42 | 31.5 (5.5) | 25–40 | ||||
| FACT-F score | ||||||||||||
| Baseline | 43.6 (8.4) | 28–52 | 47.0 (5.6) | 36–52 | 48.9 (5.8) | 36–52 | 42.3 (7.7) | 32–51 | ||||
| Endpoint (day 42) | 32.5 (8.1) | 20–46 | 47.4 (4.4) | 41 – 51 | 39.6 (8.0) | 26–48 | 43.1 (8.1) | 31–52 | ||||
| HAM-D score | ||||||||||||
| Baseline | 1.1 (2.2) | 0–7 | 0.6 (0.9) | 0–2 | 0.1 (0.4) | 0–1 | 1.0 (1.3) | 0–4 | ||||
| Endpoint (day 42) | 1.8 (2.2) | 0–7 | 0.8 (0.7) | 0–2 | 1.6 (2.2) | 0–6 | 1.6 (1.4) | 0–5 | ||||
Abbreviations: SD, standard deviation; BMI, body mass index; FACT-F, Functional Assessment of Cancer Therapy – Fatigue subscale; HAM-D, Hamilton - Depression.